Division of Urologic Surgery

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Nephrectomy 67%
3. Prostate 49%
4. Kidney 41%
5. Prostatectomy 38%
6. Robotics 37%
7. Prostate-Specific Antigen 35%
8. Dutasteride 33%
9. Urinary Bladder 30%
10. Neoplasms 28%
11. Biopsy 26%
12. Pelvic Pain 23%
13. Lower Urinary Tract Symptoms 21%
14. Early Detection of Cancer 21%
15. Urinary Bladder Neoplasms 21%
16. Renal Cell Carcinoma 20%
17. Prostatic Hyperplasia 18%
18. Chronic Pain 18%
19. Interstitial Cystitis 17%
20. Cystectomy 17%
21. Therapeutics 14%
22. Ovarian Neoplasms 12%
23. Overactive Urinary Bladder 11%
24. Pain 11%
25. Swine 10%
26. Lung Neoplasms 10%
27. Laparoscopy 10%
28. Finasteride 10%
29. Surgeons 10%
30. Colorectal Neoplasms 9%
31. Urinary Tract 9%
32. Urinary Incontinence 9%
33. Ureter 9%
34. Survival 9%
35. Cryosurgery 9%
36. Operative Time 8%
37. Recurrence 8%
38. Mortality 8%
39. Percutaneous Nephrolithotomy 8%
40. Placebos 8%
41. Serum 8%
42. Urinary Tract Infections 7%
43. Genome-Wide Association Study 7%
44. Warm Ischemia 7%
45. Kidney Neoplasms 7%
46. Urine 7%
47. Watchful Waiting 7%
48. Single Nucleotide Polymorphism 7%
49. Lymph Node Excision 7%
50. Carcinoma 7%
51. Databases 7%
52. Urinary Diversion 6%
53. Protein-Tyrosine Kinases 6%
54. Artificial Urinary Sphincter 6%
55. Confidence Intervals 6%
56. Odds Ratio 6%
57. Wounds and Injuries 6%
58. Length of Stay 6%
59. Urologists 6%
60. Quality of Life 6%
61. Castration 6%
62. Nephroureterectomy 6%
63. Neoplasm Grading 6%
64. Incidence 6%
65. Nephrons 5%
66. Stents 5%
67. Guidelines 5%
68. Stress Urinary Incontinence 5%
69. Comorbidity 5%
70. Morbidity 5%
71. Urology 5%
72. Ureteroscopy 5%
73. Radiotherapy 5%
74. Safety 5%
75. Multiparametric Magnetic Resonance Imaging 5%
76. Equipment and Supplies 5%
77. Androgen Receptors 5%
78. Magnetic Resonance Imaging 5%
79. Pediatrics 5%
80. Systematic Reviews 5%
81. Digital Rectal Examination 5%
82. Androgens 5%
83. Pressure 5%
84. Population 5%
85. Surgical Instruments 5%
86. Learning Curve 5%
87. Solid-State Lasers 5%
88. Margins of Excision 5%